A phase 2B randomised trial of hyperbaric oxygen... (2020 study) Skip to main content
RCT Am J Gastroenterol 2020

A phase 2B randomised trial of hyperbaric oxygen therapy for ulcerative colitis patients hospitalised for moderate to severe flares

Dulai PS, Buckey JC, Engstrand SS, et al., Am J Gastroenterol, 2020

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

The researchers gave hyperbaric oxygen to 20 adults in hospital with a moderate to severe ulcerative colitis flare, on top of intravenous steroids, and tested whether 5 days or 3 days of treatment worked better in those who responded early.

What They Found

In this phase 2B trial of 20 hospitalised ulcerative colitis patients, 55 percent (11 of 20) responded by day 3 of hyperbaric oxygen at 2.4 atmospheres, and stool frequency, rectal bleeding and CRP all fell significantly (p less than 0.01). Day 3 responders were randomised to 5 days or 3 days of treatment, and disease activity dropped more with 5 days (p = 0.03). Only three patients (15 percent) needed infliximab or colectomy, compared with a predicted 80 percent probability of second-line therapy. By 3 months, day 3 responders had no re-hospitalisation or colectomy, versus 66 percent of non-responders (p = 0.002). No treatment-related adverse events were observed.

What This Means for Canadian Patients

For people hospitalised with a severe ulcerative colitis flare, this small early-stage trial tested hyperbaric oxygen added to intravenous steroids. The authors say it appears effective for improving response to steroids, with 5 days giving the best response. They also say larger phase 3 trials are needed to confirm that it works.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study was small (20 patients), had no comparison group receiving steroids alone, and randomised only the day 3 responders, so the authors state that larger phase 3 trials are needed to confirm the findings.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Wound Care
Source Pubmed
PubMed ID 32745306
Year Published 2020
Journal Am J Gastroenterol

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology